MRI-PDFF response in MGL-3196 and placebo treated patients predicts reduction in ballooning and inflammation components of NAS and NASH resolution in a 36-week serial liver biopsy study Stephen Harrison1, Cynthia… Click to show full abstract
MRI-PDFF response in MGL-3196 and placebo treated patients predicts reduction in ballooning and inflammation components of NAS and NASH resolution in a 36-week serial liver biopsy study Stephen Harrison1, Cynthia Guy2, Rebecca Taub3, Mustafa Bashir2 1Oxford University, Oxford, United Kingdom; 2Duke University, Raleigh, United States; 3Madrigal Pharmaceuticals, Conshohocken, United States Email: [email protected]
               
Click one of the above tabs to view related content.